More Than Hypermobility: An interplay of Comorbidities | Dr. Brayden Yellman, MD, Rheumatologist

Поділитися
Вставка
  • Опубліковано 27 лис 2024
  • In this detailed presentation, Dr. Brayden Yellman, MD and Rheumatologist, from the Bateman Horne Center, presents his research on Comorbidities in Hypermobility, EDS, and Mast Cell Activation Syndrome.
    Presented at the November 2023 ILC Conference: The Lurking Symptomology
    Our mission at The ILC Foundation is to help individuals overcome the challenges of living with Ehlers-Danlos Syndromes and other chronic pain diseases through knowledge, sharing resources, awareness, education, peer support, and research to find cures. Learn more at theilcfoundation.org

КОМЕНТАРІ • 4

  • @Robin-s9h
    @Robin-s9h 11 місяців тому +5

    Thank you for doing this. It really helps explain things to the family.

  • @KittenCasserole
    @KittenCasserole 21 день тому

    Fantastic presentation, thanks so much for sharing

  • @EJFromTheShadows
    @EJFromTheShadows 26 днів тому

    On the slide for mast cell triggers, it lists Acetylcholine complement fragments (C3a, C4a, C5a). Would a patient with myasthenia gravis have more of these fragments that could possibly triggering their MCAS?

  • @brittanysturgill7513
    @brittanysturgill7513 29 днів тому

    I need a diagnosis do you have any colleagues in Cincinnati Ohio you can recommend? I want to be seen by a professional that understands eds . ❤